The state funds most drug-related research in Latvia within the scope of the National Programme on Drug Control and Drug Addiction Restriction 2011-17. The priority studies, which are used as indicators for the evaluation of implementation of the programme, include a general population survey, ESPAD, studies on drug use in prison, in recreational settings and among pregnant females, and studies of high-risk drug users. All these studies are funded by the Centre for Disease Prevention and Control of Latvia, where the national focal point to the EMCDDA is located, and mainly by EMCDDA grant agreement funds. The municipality of Riga provides funding for some research activities aimed at improving prevention activities at the city level.
Social studies and studies among young people are mainly conducted by university departments, while basic and applied research is carried out by the Latvian Institute of Organic Chemistry. The Latvian national focal point monitors and analyses the public health situation in the country, and disseminates drug-related research findings. Recent drug- related studies mentioned mainly include population-based surveys, while studies on demand reduction and drug policy were also mentioned.
Studies are funded by the Centre for Disease Prevention and Control of Latvia, where the national focal point to the EMCDDA is located